Search

Many common transactions with the City can be performed online

In its ongoing efforts to identify ways to serve the community better, the City of Cambridge is currently conducting a business and nonprofit organization opinion survey through February 20, 2023.

Attend an online information session to learn about Cambridge Community Electricity, a City program that provides residents and businesses with more renewable energy and stable, long-term prices for electricity.

Learn how to be safer online with accounts and passwords. We will provide an overview of frauds and scams to watch out for. To view and register for other Basic Tech Classes at the Library, please go to tinyurl.com/basictechclass. Registration is encouraged, but not required.

This online training series is designed to help main street retailers understand how they can grow their online business.

It's almost the new year – and that means it’s time to renew your Cambridge parking permit! Make sure to renew your Resident and/or Visitor Parking Permit by March 31, 2023.

Affidavit to be filled out by a condo association authorizing short-term rental units.

Affidavit to be filled out by property owners authorizing short-term rental unit(s) in the property.

On April 30, 2024, Governor Maura Healy signed into law “An Act Making Appropriations for the Fiscal Year 2024 to Provide for Supplementing certain Existing Appropriations and for Certain Other Activities and Projects.” Based on the changes made by this law, applications for alteration of premises to include an outdoor area that serves alcohol no longer need ABCC approval. These applications will now only need local board approval. The law requires that each local board establish a process by which these requests will be considered.

The U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster dose for administration to individuals 5 through 11 years of age at least five months after completion of a primary series with the Pfizer-BioNTech COVID-19 Vaccine.